Adagene Inc (NASDAQ:ADAG)
| 1.53 Delayed Data As of Sep 27 |  0.00 / 0.00%Today’s Change | 0.90 Today|||52-Week Range 2.10 | +15.47% Year-to-Date |
Latest ADAG News | Press Releases
| Is Adagene (ADAG) Outperforming Other Medical Stocks This Year? Sep 27 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.53 |
| Today’s open | 1.53 |
| Day’s range | 1.53 - 1.53 |
| Volume | 857 |
| Average volume (3 months) | 21,873 |
| Market cap | $67.1M |
Data as of 3:42pm ET, 09/27/2023
Growth & Valuation
| Earnings growth (last year) | -0.96% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -8.67% |
| P/E ratio | NM |
| Price/Sales | 6.18 |
| Price/Book | 0.80 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 29, 2023 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $9.3M |
| Annual profit (last year) | -$80.0M |
| Net profit margin | -860.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
Chart unavailable
